Inventors:
Williamson Ziegler Bradford - San Francisco CA, US
James Pennington - Lafayette CA, US
Stephen Rosenfield - San Francisco CA, US
Assignee:
INTERMUNE, INC. - Brisbane CA
International Classification:
A61K 38/21, G06Q 50/00, A61P 11/00, A61M 5/14, G06Q 30/00
US Classification:
424 855, 705 14, 6048911, 604502, 604181
Abstract:
The present invention provides a marketing system and methods for marketing a dosage form comprising interferon gamma (IFN-γ) to a patient in need thereof, for the treatment of idiopathic pulmonary fibrosis (IPF). The present invention further provides a method for increasing patient compliance. The present invention further provides methods of treatment and dosage forms compatible for use in the marketing systems and methods of the invention.